Author: Dr. David Lowemann

WHO to Back Weight-Loss Drugs for Adults Globally

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first time, a memo reviewed by Reuters on Thursday shows, marking a shift in its approach to treating the global health problem. The UN agency also called… Read Full Article (External Site) Dr. David LowemannDr. […]

Published on May 1, 2025

Ozempic Effective Against Fatty Liver Disease

The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has found. Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ – 63%, compared with 34% of… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., […]

Published on May 1, 2025

Move more, think sharper

A brisk walk, a splash of water aerobics, or even a light jog around the block — if your heart rate goes up then so too will your brain health according to new research. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future […]

Published on May 1, 2025